The Neurobehavioral Effects of Anesthetics on Infants With Hearing Impairment(Retrospective Research)
NCT ID: NCT04291274
Last Updated: 2021-09-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
17 participants
OBSERVATIONAL
2019-11-01
2019-12-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Neurobehavioral Effects of Anesthetics on Infants With Hearing Impairment
NCT04255485
Neurodevelopment of Infants Exposed to General Anesthesia: a Multi-center Investigation
NCT03629093
Study of the Effect of General Anesthesia on Children's Behavior
NCT05164913
Neurodevelopmental Outcome After Prenatal Anesthesia
NCT06052878
Neuraxial Labor Analgesia and Offspring Neurodevelopment
NCT04964206
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
inhalation anesthesia group
Unilateral and Bilateral cochlear implantation,which used inhalation anesthesia
No interventions assigned to this group
intravenous anesthesia group
Unilateral and Bilateral cochlear implantation, which used intravenous anesthesia
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 6 to 36-month-old child
* Normal body weight
* Children with normal structures of the inner ear and auditory nerve
* Children without contraindications to anesthesia and surgery
* Patients who have not participated in other clinical trials
* Without any acute infectious diseases or systematic diseases
Exclusion Criteria
* With other illness which could affects curative effect of recovery, such as inner ear malformations (except for large vestibular aqueduct syndrome), auditory vestibular nerve dysplasia, dysgnosia and mental disease;
* Inability to cooperate with the hearing evaluation and the language training
* Cute and chronic otitis media and mastoiditis, unhealed tympanic membrane perforation
* Abnormal structure of brain, including white matter dysplasia, Demyelinating Diseases
6 Months
36 Months
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jingjie Li
associate chief physician
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jingjie Li, M.D
Role: STUDY_CHAIR
Shanghai No.9 People's Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Shanghai ninth people's hospital
Shanghai, , China
Shanghai No.9 People's Hospital
Shanghai, , China
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Zhang L, Cheng Y, Xue Z, Li J, Wu N, Yan J, Wang J, Wang C, Chen W, Zhou T, Qiu Z, Jiang H. Sevoflurane impairs m6A-mediated mRNA translation and leads to fine motor and cognitive deficits. Cell Biol Toxicol. 2022 Apr;38(2):347-369. doi: 10.1007/s10565-021-09601-4. Epub 2021 Apr 29.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SH9H-2019-T293-2
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.